Trailing-twelve-month (TTM) revenue is $26.69 Billion with a year-over-year growth of (3.78%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $6,402,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $6,557,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-31 | $6,650,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q2 FY2026Period ended 2026-06-30 | $7,085,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $26,694,000,000 |
Current P/S: $39,781,356,180 market capitalization ÷ $26,694,000,000 TTM revenue = 1.49x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $7.08B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Corporate Nonsegment and Reconciling Items | $1.4B | $347M | $392M | $479M | $870M | $73M |
| General Insurance Segment | $26.6B | $28.4B | $27.7B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| International | $15.4B | $16.4B | $14.8B | $13.2B | $14.2B | $14.1B |
| North America | $34.1B | $31.0B | $41.6B | $33.6B |
$26.69B
$26.69 Billion
(3.78%)
vs. $27.74B a year ago (TTM)
(9.93%)
5 Year compound annual growth rate
1 Year
(3.78%)
3 Year
(15.47%)
5 Year
(9.93%)
10 Year
(6.78%)
15 Year
(6.68%)
20 Year
(6.75%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $26.77B | ($496.00M) | (1.82%) |
| 2024 | $27.27B | ($689.00M) | (2.46%) |
| 2023 | $27.96B | ($2.02B) | (6.73%) |
| 2022 | $29.98B | ($22.01B) | (42.34%) |
| 2021 | $51.98B | +$8.15B | +18.58% |
| 2020 |
TTM Growth
(3.78%)
3-Year CAGR
(15.47%)
5-Year CAGR
(9.93%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $28.5B |
| $27.7B |
| N/A |
| Life and Retirement | $17.3B | $19.6B | $17.7B | N/A | N/A | N/A |
|---|
| Total Reconciling Items | -$995M | $3.8B | $10.7B | -$1.1B | -$548M | N/A |
|---|
| $13.0B |
| $12.7B |
| $43.84B |
| ($5.95B) |
| (11.96%) |
| 2019 | $49.79B | +$2.31B | +4.87% |
| 2018 | $47.48B | ($2.45B) | (4.90%) |
| 2017 | $49.93B | ($2.82B) | (5.35%) |
| 2016 | $52.75B | ($6.17B) | (10.47%) |
